Mavacoxib

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Mavacoxib (trade name Trocoxil) is a veterinary drug used to treat pain and inflammation in dogs with degenerative joint disease.^[1] It acts as a COX-2 inhibitor.^[2]

References

↑ European Public Assessment Report (EPAR): Trocoxil, European Medicines Agency
↑ Cox, S. R.; Lesman, S. P.; Boucher, J. F.; Krautmann, M. J.; Hummel, B. D.; Savides, M.; Marsh, S.; Fielder, A.; Stegemann, M. R. (2010). “The pharmacokinetics of mavacoxib, a long-acting COX-2 inhibitor, in young adult laboratory dogs”. Journal of Veterinary Pharmacology and Therapeutics. 33 (5): 461–70. doi:10.1111/j.1365-2885.2010.01165.x. PMID 20840390.

Template:Veterinary-med-stub Template:Musculoskeletal-drug-stub

[1] European Public Assessment Report (EPAR): Trocoxil, European Medicines Agency

[2] Cox, S. R.; Lesman, S. P.; Boucher, J. F.; Krautmann, M. J.; Hummel, B. D.; Savides, M.; Marsh, S.; Fielder, A.; Stegemann, M. R. (2010). “The pharmacokinetics of mavacoxib, a long-acting COX-2 inhibitor, in young adult laboratory dogs”. Journal of Veterinary Pharmacology and Therapeutics. 33 (5): 461–70. doi:10.1111/j.1365-2885.2010.01165.x. PMID 20840390.

[1]

[2]